FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Damon Meyer

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Devices

Drug Delivery Systems

Procedures

Concepts & Ideas

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Stephen C Alley; Dennis R Benjamin; Scott C Jeffrey; Nicole M Okeley; Damon L Meyer; Russell J Sanderson; Peter D Senter
Contribution of linker stability to the activities of anticancer immunoconjugates.
Maureen C Ryan; Michelle A Hering; David Peckham; Charlotte F McDonagh; Lindsay Brown; Kristine M Kim; Damon L Meyer; Roger F Zabinski; Iqbal Grewal; Paul J Carter
Antibody targeting of B-cell maturation antigen on malignant plasma cells.
Kai Temming; Damon L Meyer; Roger F Zabinski; Peter D Senter; Klaas Poelstra; Grietje Molema; Robbert J Kok
Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Damon Meyer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2008: Stephen C Alley; Dennis R Benjamin; Scott C Jeffrey; Nicole M Okeley; Damon L Meyer; Russell J Sanderson; Peter D Senter
Contribution of linker stability to the activities of anticancer immunoconjugates.
Bioconjugate chemistry 2008;19(3):759-65.
2007: Maureen C Ryan; Michelle A Hering; David Peckham; Charlotte F McDonagh; Lindsay Brown; Kristine M Kim; Damon L Meyer; Roger F Zabinski; Iqbal Grewal; Paul J Carter
Antibody targeting of B-cell maturation antigen on malignant plasma cells.
Molecular cancer therapeutics 2007;6(11):3009-18.
2007: Kai Temming; Damon L Meyer; Roger F Zabinski; Peter D Senter; Klaas Poelstra; Grietje Molema; Robbert J Kok
Improved efficacy of alphavbeta3-targeted albumin conjugates by conjugation of a novel auristatin derivative.
Molecular pharmaceutics 2007;4(5):686-94.
2007: Scott C Jeffrey; Minh T Nguyen; Ruth F Moser; Damon L Meyer; Jamie B Miyamoto; Peter D Senter
Minor groove binder antibody conjugates employing a water soluble beta-glucuronide linker.
Bioorganic & medicinal chemistry letters 2007;17(8):2278-80.
2006: Kai Temming; Damon L Meyer; Roger F Zabinski; Eli C F Dijkers; Klaas Poelstra; Grietje Molema; Robbert J Kok
Evaluation of RGD-targeted albumin carriers for specific delivery of auristatin E to tumor blood vessels.
Bioconjugate chemistry 2006;17(6):1385-94.
2006: M. Sutherland; Russell J Sanderson; Kristine A Gordon; Jamie Andreyka; Charles G Cerveny; Changpu Yu; Timothy S Lewis; Damon L Meyer; Roger F Zabinski; Svetlana O Doronina; Peter D Senter; Che-Leung Law; Alan F Wahl
Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates.
The Journal of biological chemistry 2006;281(15):10540-7.
2006: Kam Fai Tse; Michael Jeffers; Vincent A Pollack; Denise A McCabe; Melanie L Shadish; Nikolai V Khramtsov; Craig Hackett; Suresh G Shenoy; Bing Kuang; Ferenc L Boldog; John MacDougall; Luca Rastelli; John Herrmann; Michael Gallo; Gadi Gazit-Bornstein; Peter D Senter; Damon L Meyer; Henri S Lichenstein; William J LaRochelle
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1373-82.
2006: Che-Leung Law; Kristine A Gordon; Brian E Toki; Andrew K Yamane; Michelle A Hering; Charles G Cerveny; Joseph Petroziello; Maureen C Ryan; Leia Smith; Ronald Simon; Guido Sauter; Ezogelin Oflazoglu; Svetlana O Doronina; Damon L Meyer; Joseph A Francisco; Paul Carter; Peter D Senter; John A Copland; Christopher G Wood; Alan F Wahl
Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.
Cancer research 2006;66(4):2328-37.
2006: Scott C Jeffrey; Minh T Nguyen; Jamie Andreyka; Damon L Meyer; Svetlana O Doronina; Peter D Senter
Dipeptide-based highly potent doxorubicin antibody conjugates.
Bioorganic & medicinal chemistry letters 2006;16(2):358-62.
2006: Svetlana O Doronina; Brian A Mendelsohn; Tim D Bovee; Charles G Cerveny; Stephen C Alley; Damon L Meyer; Ezogelin Oflazoglu; Brian E Toki; Russell J Sanderson; Roger F Zabinski; Alan F Wahl; Peter D Senter
Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity.
Bioconjugate chemistry 2006;17(1):114-24.
2005: Kevin J Hamblett; Oliver W Press; Damon L Meyer; Donald K Hamlin; Axworthy Don; D Scott Wilbur; Patrick S Stayton
Role of biotin-binding affinity in streptavidin-based pretargeted radioimmunotherapy of lymphoma.
Bioconjugate chemistry 2005;16(1):131-8.
2004: Che-Leung Law; Charles G Cerveny; Kristine A Gordon; Kerry Klussman; Bruce J Mixan; Dana F Chace; Damon L Meyer; Svetlana O Doronina; Clay B Siegall; Joseph A Francisco; Peter D Senter; Alan F Wahl
Efficient elimination of B-lineage lymphomas by anti-CD20-auristatin conjugates.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(23):7842-51.
2004: Kevin J Hamblett; Peter D Senter; Dana F Chace; Michael M C Sun; Joel Lenox; Charles G Cerveny; Kim M Kissler; Starr X Bernhardt; Anastasia K Kopcha; Roger F Zabinski; Damon L Meyer; Joseph A Francisco
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(20):7063-70.
2004: Kerry Klussman; Bruce J Mixan; Charles G Cerveny; Damon L Meyer; Peter D Senter; Alan F Wahl
Secondary mAb--vcMMAE conjugates are highly sensitive reporters of antibody internalization via the lysosome pathway.
Bioconjugate chemistry 2004;15(4):765-73.
2003: Joseph A Francisco; Charles G Cerveny; Damon L Meyer; Bruce J Mixan; Kerry Klussman; Dana F Chace; Starr X Rejniak; Kristine A Gordon; Ron DeBlanc; Brian E Toki; Che-Leung Law; Svetlana O Doronina; Clay B Siegall; Peter D Senter; Alan F Wahl
cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity.
Blood 2003;102(4):1458-65.
2003: Svetlana O Doronina; Brian E Toki; Michael Y Torgov; Brian A Mendelsohn; Charles G Cerveny; Dana F Chace; Ron L DeBlanc; R Patrick Gearing; Tim D Bovee; Clay B Siegall; Joseph A Francisco; Alan F Wahl; Damon L Meyer; Peter D Senter
Development of potent monoclonal antibody auristatin conjugates for cancer therapy.
Nature biotechnology 2003;21(7):778-84.
2003: Krishnan Subbiah; Donald K Hamlin; John M Pagel; D Scott Wilbur; Damon L Meyer; Axworthy Don; Robert W Mallett; Louis J Theodore; Patrick S Stayton; Oliver W Press
Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(3):437-45.
2002: D Scott Wilbur; Donald K Hamlin; Damon L Meyer; Robert W Mallett; Janna Quinn; Robert L Vessella; Oliver W Press
Streptavidin in antibody pretargeting. 3. Comparison of biotin binding and tissue localization of 1,2-cyclohexanedione and succinic anhydride modified recombinant streptavidin.
Bioconjugate chemistry 2002;13(3):611-20.
2001: Oliver W Press; M Corcoran; Krishnan Subbiah; Donald K Hamlin; D Scott Wilbur; T Johnson; Louis J Theodore; E Yau; Robert W Mallett; Damon L Meyer; Axworthy Don
A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts.
Blood 2001;98(8):2535-43.
2001: Mark Hylarides; Robert W Mallett; Damon L Meyer
A robust method for the preparation and purification of antibody/streptavidin conjugates.
Bioconjugate chemistry 2001;12(3):421-7.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.